Our Oncology and Research teams are working in partnership with The University of Manchester and Douglas Pharmaceuticals to develop a new treatment of early-stage cervical cancer.
The research is looking into whether a drug, commonly used to treat HIV, might prevent early-stage cervical cancer.
Dr. Pierre Martin-Hirsch, our Consultant Gynaecological Oncologist and Director of Research will be leading the clinical trial in the UK; he said: “This is a really exciting project and something that I am incredibly proud to be involved in. This new treatment could offer hope for millions of women across the world who are at risk of cervical cancer.
A clinical trial to try and develop this treatment is due to start in early 2018.